Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
07 February 2012Website:
http://www.acastipharma.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Mon, 01 Jul 2024 21:40:46 GMTDividend
Analysts recommendations
Institutional Ownership
ACST Latest News
PRINCETON, N.J., June 21, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of nimodipine that addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (aSAH), today announced financial results and business highlights for the year ended March 31, 2024.
As the main stock indices like the S&P 500 and Nasdaq continue to climb, penny stocks are becoming attractive for those seeking significant returns. Despite their reputation for extreme price fluctuations and high risk, they offer the potential for impressive gains, especially in a bull market.
PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) ("Acasti" or the "Company"), a late-stage, biopharma company advancing GTX-104 its novel formulation of nimodipine that addresses the high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (aSAH), today announced that a poster presenting a pharmacokinetic comparison of GTX-104 with oral nimodipine has been accepted for presentation at the 2023 Neurocritical Care Society (NCS) annual meeting, to be held in Phoenix, AZ August 15-18, 2023.
What type of business is Acasti Pharma?
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
What sector is Acasti Pharma in?
Acasti Pharma is in the Healthcare sector
What industry is Acasti Pharma in?
Acasti Pharma is in the Biotechnology industry
What country is Acasti Pharma from?
Acasti Pharma is headquartered in United States
When did Acasti Pharma go public?
Acasti Pharma initial public offering (IPO) was on 07 February 2012
What is Acasti Pharma website?
https://www.acastipharma.com
Is Acasti Pharma in the S&P 500?
No, Acasti Pharma is not included in the S&P 500 index
Is Acasti Pharma in the NASDAQ 100?
No, Acasti Pharma is not included in the NASDAQ 100 index
Is Acasti Pharma in the Dow Jones?
No, Acasti Pharma is not included in the Dow Jones index
When does Acasti Pharma report earnings?
The next expected earnings date for Acasti Pharma is 09 August 2024